相关实验视频

Updated: May 25, 2025

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

多西塔克塞尔微粒:一种新的配方来减少过敏反应

Lanlan Xiang¹, Hao Wang¹, Jiajie Liu¹

¹National Material Experimental Teaching Demonstration Center, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.

|February 26, 2025

概括

纳米细胞封装的多塞塔克塞尔提供了一种减少这种癌症药物常见过敏反应的新方法. 这种配方避免了血液溶解和刺激等副作用,改善了患者的治疗.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
在瘤学瘤学.

背景情况:

多塞塔塞尔是一种重要的化疗药物,但由于其溶解剂Tween-80,它会引起过敏反应.
德克萨米他往往需要在多塞塔克塞尔注射之前进行过敏预防.
纳米微粒是药物输送的有希望的替代品,因为其可溶性和稳定性得到了改善.

研究的目的:

为减少过敏反应开发和评估载有多塞素的纳米细胞.
研究mPEG-PLA-Lys(Fmoc) 纳米细胞作为多塞塔塞尔药物递送系统的潜力.

主要方法:

工程设计的mPEG-PLA-Lys(Fmoc) 纳米细胞 (m=45,n=10) 用于封装dcetaxel.
研究了纳米细胞载体的自组装特性.
进行动物研究以评估过敏反应和局部刺激.

主要成果:

载有多塞塔克塞尔的纳米细胞并没有在子中引起血液溶解.
在子中没有观察到血管或肌肉刺激.
该配方没有引起几内亚猪的过敏反应.

结论:

纳米囊封装的多塞塔塞尔显著减少过敏反应.
这种方法通过减轻不良影响来增强多塞塔塞尔的治疗潜力.
载有多西的纳米细胞代表了更安全的癌症化疗的有希望的策略.

关键词:

过敏反应过敏反应多塞塔克塞尔 (Docetaxel) 是一种药物.它们是纳米微粒.

更多相关视频

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

相关概念视频

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...